enteroporc coli ac
ceva santé animale - clostridium perfringens type c, beta1 toxoid / clostridium perfringens, type a, alpha toxoid / clostridium perfringens, type a, beta2 toxoid / escherichia coli, fimbrial adhesin f4ab / escherichia coli, fimbrial adhesin f4ac / escherichia coli, fimbrial adhesin f5 / escherichia coli, fimbrial adhesin f6 - immunologicals for suidae, inactivated bacterial vaccines (including mycoplasma, toxoid and chlamydia) escherichia + clostridium - Χοίροι - for the passive immunisation of progeny by active immunisation of pregnant sows and gilts to reduce:- clinical signs (severe diarrhoea) and mortality caused by escherichia coli strains expressing the fimbrial adhesins f4ab, f4ac, f5 and f6- clinical signs (diarrhoea during the first days of life) associated with clostridium perfringens type a expressing alpha and beta 2 toxins- clinical signs and mortality associated with haemorrhagic and necrotising enteritis caused by clostridium perfringens type c expressing beta1 toxin.
ultifend nd ibd
ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - Ανοσολογικά φάρμακα - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).
vectormune fp ilt
ceva-phylaxia co. ltd. - recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live - Κοτόπουλο - for active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.
milbeguard duo 2,5 mg / 25 mg μασώμενα δισκία για μικρόσωμους σκύλους και κουτάβια
qp54ab51 - granted - ceva sante animale - panchris feeds (veterinary) ltd
milbeguard duo 12,5 mg / 125 mg μασώμενα δισκία για σκύλους
qp54ab51 - granted - ceva sante animale - panchris feeds (veterinary) ltd
milbeguard duo 25 mg / 250 mg μασώμενα δισκία για μεγαλόσωμους σκύλους
qp54ab51 - granted - ceva sante animale - panchris feeds (veterinary) ltd
milbeguard duo 4 mg / 10 mg επικαλυμμένα με λεπτό υμένιο δισκία για μικρόσωμες γάτες και γατάκια
qp54ab51 - granted - ceva sante animale - panchris feeds (veterinary) ltd
milbeguard duo 16 mg / 40 mg επικαλυμμένα με λεπτό υμένιο δισκία για γάτες
qp54ab51 - granted - ceva sante animale - panchris feeds (veterinary) ltd
mencevax ps.inj.sol 50mc/type
glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.Β.Ε. Λεωφ. Κηφισίας 266,, 152 32 152 32, Χαλάνδρι 210-6882100 - ps.inj.sol (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - 50mc/type
mencevax acwy ps.inj.sol (50+50+50+50)mg/0,5ml
glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ ΑΝΩΝΥΜΗ ΕΜΠΟΡΙΚΗ ΚΑΙ ΒΙΟΜΗΧΑΝΙΚΗ ΕΤΑΙΡΕΙΑ ΦΑΡΜΑΚΕΥΤΙΚΩΝ ΠΡΟΪΟΝΤΩΝ Δ.Τ. glaxosmithkline ΜΟΝΟΠΡΟΣΩΠΗ Α.Ε.Β.Ε. Λεωφ. Κηφισίας 266,, 152 32 152 32, Χαλάνδρι 210-6882100 - neisseria meningitidis a; neisseria meningitidis c; neisseria meningitidis w135; neisseria meningitidis y - ps.inj.sol (ΚΟΝΙΣ ΚΑΙ ΔΙΑΛΥΤΗΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ) - (50+50+50+50)mg/0,5ml - neisseria meningitidis a; neisseria meningitidis c; neisseria meningitidis w135; neisseria meningitidis y - meningococcus a,c,y,w-135, tetravalent purified polysaccharides antigen